SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-08-032438
Filing Date
2008-05-28
Accepted
2008-05-28 16:31:26
Documents
2
Period of Report
2008-05-28

Document Format Files

Seq Description Document Type Size
1 v115939_6k.htm 6-K 28348
2 GRAPHIC logo.jpg GRAPHIC 10206
  Complete submission text file 0001144204-08-032438.txt   43931
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 08863857
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1